,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Alopecia,3,17135367
1,22.1,Hair colour changes,3,17135367
2,22.1,Hair disorder,3,17135367
3,22.1,Hair texture abnormal,3,17135367
0,22.1,Alopecia,3,17135372
0,22.1,Lung disorder,6,17135407
0,22.1,Haematochezia,6,17135413
1,22.1,Arthritis,3,17135413
2,22.1,Dry skin,3,17135413
3,22.1,Pruritus,3,17135413
4,22.1,Muscular weakness,6,17135413
0,22.1,Memory impairment,2,17135449
1,22.1,Blood albumin increased,2,17135449
0,22.1,Radiation pneumonitis,6,17135511
1,22.1,Pneumocystis jirovecii pneumonia,1,17135511
0,22.1,Liver disorder,2,17135562
0,22.1,Pollakiuria,6,17135579
1,22.1,Fatigue,6,17135579
2,22.1,Weight increased,6,17135579
3,22.1,Hot flush,6,17135579
4,22.1,Alcohol intolerance,6,17135579
5,22.1,Haemorrhage,1,17135579
6,22.1,Uterine mass,6,17135579
0,22.1,Cardiovascular disorder,6,17135612
1,22.1,Blood creatinine increased,6,17135612
2,22.1,Inappropriate schedule of product administration,6,17135612
3,22.1,Haemophagocytic lymphohistiocytosis,4,17135612
4,22.1,Haematuria,1,17135612
5,22.1,Haemoglobin abnormal,1,17135612
0,22.1,Death,5,17135632
0,22.1,Pain,6,17135635
1,22.1,Neoplasm progression,6,17135635
2,22.1,Neutrophil count decreased,6,17135635
3,22.1,White blood cell count decreased,6,17135635
4,22.1,Weight decreased,6,17135635
5,22.1,Death,5,17135635
0,22.1,Pruritus,6,17135638
1,22.1,Skin lesion,6,17135638
2,22.1,Chest pain,6,17135638
3,22.1,Platelet count decreased,6,17135638
4,22.1,Drug hypersensitivity,6,17135638
5,22.1,Pulmonary oedema,6,17135638
0,22.1,Death,5,17135647
0,22.1,Neoplasm progression,6,17135652
1,22.1,Death,5,17135652
0,22.1,Cardiac disorder,6,17135656
1,22.1,Carbon dioxide increased,6,17135656
2,22.1,Death,5,17135656
0,22.1,Dementia,6,17135661
0,22.1,Dry mouth,3,17135699
1,22.1,Urine abnormality,1,17135699
2,22.1,Taste disorder,3,17135699
3,22.1,Alopecia,3,17135699
4,22.1,Nervousness,1,17135699
5,22.1,Diarrhoea,1,17135699
6,22.1,Urinary tract infection,1,17135699
7,22.1,Urine analysis abnormal,1,17135699
8,22.1,Dizziness,1,17135699
9,22.1,Hypokalaemia,1,17135699
10,22.1,Bladder dysfunction,3,17135699
11,22.1,Ileus,1,17135699
12,22.1,Asthenia,1,17135699
0,22.1,Ventricular fibrillation,5,17135709
1,22.1,Cardiac failure,6,17135709
0,22.1,Ileus,1,17135726
0,22.1,Bone marrow failure,1,17135732
0,22.1,Polyneuropathy,2,17135733
1,22.1,Decreased appetite,2,17135733
0,22.1,General physical health deterioration,2,17135742
1,22.1,Fall,2,17135742
2,22.1,Lung disorder,2,17135742
0,22.1,Epistaxis,2,17135784
1,22.1,Mucocutaneous haemorrhage,2,17135784
0,22.1,Fistula,1,17135827
1,22.1,Abdominal abscess,2,17135827
0,22.1,Drug resistance,6,17135954
0,22.1,Pleural effusion,3,17135962
1,22.1,Death,5,17135962
0,22.1,Febrile neutropenia,1,17135978
1,22.1,Off label use,6,17135978
2,22.1,Pyrexia,3,17135978
3,22.1,Erysipelas,1,17135978
0,22.1,Proteinuria,1,17135982
1,22.1,Cardiac failure,3,17135982
0,22.1,Intestinal perforation,5,17135987
0,22.1,Malignant neoplasm progression,6,17136014
1,22.1,Drug resistance,6,17136014
0,22.1,Adrenal insufficiency,3,17136019
0,22.1,Fistula,6,17136021
0,22.1,Adrenal insufficiency,1,17136028
1,22.1,Oedema,2,17136028
2,22.1,Product use in unapproved indication,6,17136028
3,22.1,Fatigue,1,17136028
4,22.1,Muscle spasms,1,17136028
5,22.1,Weight increased,2,17136028
6,22.1,Malaise,1,17136028
0,22.1,Clostridium difficile infection,6,17136032
1,22.1,Pneumonia,6,17136032
0,22.1,Prostate cancer metastatic,6,17136048
0,22.1,Neurotoxicity,6,17136065
0,22.1,Subclavian vein thrombosis,6,17136078
1,22.1,Neuropathy peripheral,6,17136078
2,22.1,Hypersensitivity,6,17136078
3,22.1,Haematotoxicity,6,17136078
4,22.1,Adverse drug reaction,6,17136078
5,22.1,Disease progression,6,17136078
6,22.1,Erysipelas,6,17136078
7,22.1,Breast cancer metastatic,2,17136078
0,22.1,Anaemia,2,17136083
1,22.1,Thrombocytopenia,2,17136083
2,22.1,Leukopenia,2,17136083
0,22.1,Recurrent cancer,6,17136101
1,22.1,Intentional product misuse,6,17136101
2,22.1,Toxicity to various agents,6,17136101
0,22.1,Metastases to central nervous system,3,17136103
1,22.1,Dizziness,6,17136103
0,22.1,Drug resistance,6,17136107
0,22.1,Death,5,17136112
1,22.1,Off label use,6,17136112
0,22.1,Blood testosterone increased,6,17136135
0,22.1,Treatment noncompliance,6,17136147
0,22.1,Death,5,17136166
0,22.1,Fatigue,1,17136169
1,22.1,Fall,6,17136169
2,22.1,Blood iron decreased,6,17136169
3,22.1,Facial bones fracture,6,17136169
4,22.1,White blood cell count decreased,6,17136169
5,22.1,Hepatic enzyme abnormal,6,17136169
6,22.1,Neoplasm progression,6,17136169
7,22.1,Chest pain,1,17136169
8,22.1,Red blood cell count decreased,6,17136169
9,22.1,Neuropathy peripheral,6,17136169
10,22.1,Chest discomfort,1,17136169
11,22.1,Gastric disorder,1,17136169
0,22.1,Agitation,3,17136173
1,22.1,Underweight,3,17136173
2,22.1,Death,5,17136173
3,22.1,Mobility decreased,3,17136173
0,22.1,Neoplasm progression,5,17136176
1,22.1,Neutrophil count decreased,6,17136176
2,22.1,Fear,6,17136176
3,22.1,Feeding disorder,6,17136176
4,22.1,White blood cell count decreased,6,17136176
5,22.1,Bone pain,6,17136176
6,22.1,Vomiting,3,17136176
0,22.1,Pancreatic carcinoma recurrent,6,17136284
0,22.1,Gastric cancer,5,17136301
1,22.1,Death,5,17136301
2,22.1,Product use in unapproved indication,6,17136301
3,22.1,Malignant neoplasm progression,5,17136301
0,22.1,Cardiac arrest,5,17136365
1,22.1,Acne,3,17136365
2,22.1,Peripheral swelling,3,17136365
3,22.1,Red blood cell count decreased,6,17136365
4,22.1,Pruritus,3,17136365
5,22.1,General physical health deterioration,6,17136365
6,22.1,Epistaxis,6,17136365
7,22.1,Renal failure,6,17136365
8,22.1,Extraocular muscle disorder,3,17136365
9,22.1,Depressed mood,3,17136365
10,22.1,Rash,3,17136365
0,22.1,Pyrexia,6,17136417
1,22.1,Drug ineffective,6,17136417
2,22.1,Completed suicide,5,17136417
3,22.1,Drug resistance,6,17136417
4,22.1,Malignant neoplasm progression,5,17136417
5,22.1,Head discomfort,6,17136417
6,22.1,Asthenia,6,17136417
7,22.1,General physical health deterioration,6,17136417
8,22.1,Feeding disorder,6,17136417
9,22.1,Dyspepsia,6,17136417
10,22.1,Body temperature decreased,6,17136417
11,22.1,Gait disturbance,6,17136417
12,22.1,Psychiatric symptom,6,17136417
0,22.1,Bone marrow failure,6,17136418
1,22.1,Anaemia,3,17136418
2,22.1,Platelet count decreased,1,17136418
0,22.1,Completed suicide,5,17136424
0,22.1,Impaired quality of life,6,17136492
1,22.1,Psychological trauma,6,17136492
2,22.1,Alopecia,2,17136492
3,22.1,Anxiety,6,17136492
4,22.1,Pain,6,17136492
5,22.1,Emotional distress,6,17136492
0,22.1,Disease progression,6,17136546
1,22.1,Recurrent cancer,6,17136546
2,22.1,Adverse drug reaction,6,17136546
0,22.1,Chromaturia,3,17136567
1,22.1,Peripheral swelling,3,17136567
2,22.1,Swelling face,3,17136567
0,22.1,Malignant neoplasm progression,6,17136583
0,22.1,Sepsis,3,17136603
0,22.1,Hyponatraemia,1,17136604
0,22.1,Metastases to liver,6,17136611
1,22.1,Hepatic failure,6,17136611
2,22.1,Breast cancer,5,17136611
3,22.1,Malignant neoplasm progression,5,17136611
0,22.1,Paraesthesia,2,17136742
1,22.1,Amenorrhoea,2,17136742
0,22.1,Decubitus ulcer,1,17136746
0,22.1,Breast cancer,6,17136750
1,22.1,Malignant neoplasm progression,6,17136750
0,22.1,Sepsis,2,17136781
1,22.1,Neutropenia,6,17136781
2,22.1,Metastasis,6,17136781
3,22.1,Thrombocytopenia,2,17136781
4,22.1,Off label use,6,17136781
5,22.1,Cancer pain,6,17136781
6,22.1,Hepatic failure,5,17136781
7,22.1,Haematotoxicity,1,17136781
8,22.1,Malignant neoplasm progression,6,17136781
9,22.1,Metastases to liver,6,17136781
10,22.1,Therapeutic response decreased,6,17136781
11,22.1,Invasive ductal breast carcinoma,6,17136781
12,22.1,Drug intolerance,6,17136781
0,22.1,Cardiac disorder,6,17136785
1,22.1,Fluid retention,6,17136785
2,22.1,Death,5,17136785
0,22.1,Phlebitis,3,17136841
1,22.1,Urinary tract infection,3,17136841
0,22.1,Neutropenia,2,17136842
1,22.1,Leukocoria,2,17136842
0,22.1,Duodenal ulcer,2,17136845
0,22.1,Hair colour changes,6,17136872
1,22.1,Blood pressure increased,6,17136872
2,22.1,Rash,6,17136872
0,22.1,Diarrhoea,6,17136877
1,22.1,Fatigue,2,17136877
2,22.1,Bone pain,6,17136877
3,22.1,Bone marrow failure,6,17136877
4,22.1,Myalgia,6,17136877
0,22.1,Underdose,1,17136912
1,22.1,Inappropriate schedule of product administration,1,17136912
0,22.1,Hyponatraemia,1,17136942
1,22.1,Embolism,3,17136942
0,22.1,Thrombocytopenia,1,17136955
1,22.1,Immune-mediated adverse reaction,1,17136955
2,22.1,Rectal haemorrhage,1,17136955
0,22.1,Alopecia,3,17136986
0,22.1,Dysphagia,1,17137009
1,22.1,Recurrent cancer,6,17137009
2,22.1,Neoplasm progression,3,17137009
3,22.1,Vomiting,1,17137009
4,22.1,Chest pain,1,17137009
5,22.1,Somnolence,1,17137009
6,22.1,Arthralgia,6,17137009
7,22.1,Abdominal pain,6,17137009
8,22.1,Intentional product use issue,6,17137009
9,22.1,Drug ineffective,6,17137009
10,22.1,Chest discomfort,6,17137009
11,22.1,Fatigue,3,17137009
0,22.1,Blood potassium increased,6,17137010
1,22.1,Vomiting,6,17137010
2,22.1,Dehydration,6,17137010
3,22.1,Psychomotor hyperactivity,6,17137010
4,22.1,Motor dysfunction,6,17137010
5,22.1,Gastrointestinal stoma complication,6,17137010
6,22.1,Underdose,6,17137010
7,22.1,Abdominal pain,6,17137010
0,22.1,Hypertension,6,17137011
1,22.1,Sepsis,6,17137011
2,22.1,Haemorrhage,1,17137011
3,22.1,Malignant neoplasm progression,5,17137011
0,22.1,Neutropenia,1,17137036
0,22.1,Dehydration,1,17137049
1,22.1,Neoplasm progression,6,17137049
2,22.1,Pyrexia,6,17137049
3,22.1,Back pain,6,17137049
4,22.1,Red blood cell count decreased,6,17137049
5,22.1,Leukopenia,3,17137049
6,22.1,Rhinorrhoea,6,17137049
7,22.1,Vomiting,1,17137049
8,22.1,Gastric ulcer,6,17137049
9,22.1,Decreased appetite,6,17137049
10,22.1,Cough,6,17137049
11,22.1,Nausea,6,17137049
12,22.1,Asthenia,6,17137049
13,22.1,Anaemia,3,17137049
14,22.1,Chest pain,6,17137049
15,22.1,Headache,6,17137049
16,22.1,White blood cell count decreased,1,17137049
17,22.1,Taste disorder,6,17137049
18,22.1,Sinus congestion,6,17137049
19,22.1,Oesophageal pain,6,17137049
20,22.1,Fatigue,3,17137049
21,22.1,Musculoskeletal chest pain,6,17137049
22,22.1,Weight decreased,1,17137049
23,22.1,Arthralgia,6,17137049
24,22.1,Laboratory test abnormal,6,17137049
0,22.1,Tachycardia,2,17137061
1,22.1,Asthenia,2,17137061
2,22.1,Bladder disorder,2,17137061
3,22.1,Mobility decreased,2,17137061
4,22.1,Confusional state,2,17137061
5,22.1,Cardiac murmur,2,17137061
6,22.1,Fatigue,2,17137061
7,22.1,Decreased appetite,2,17137061
0,22.1,Prostatic specific antigen increased,2,17137063
0,22.1,Prostatic specific antigen increased,2,17137072
0,22.1,Pulmonary oedema,3,17137075
1,22.1,Fatigue,2,17137075
2,22.1,Dyspnoea,6,17137075
3,22.1,Anaemia,6,17137075
4,22.1,Hypothyroidism,6,17137075
5,22.1,Product use in unapproved indication,3,17137075
6,22.1,Dehydration,1,17137075
7,22.1,Diarrhoea,1,17137075
0,22.1,Arthralgia,6,17137076
1,22.1,Hot flush,3,17137076
2,22.1,Death,5,17137076
3,22.1,Intentional dose omission,6,17137076
0,22.1,Intercepted product preparation error,,17137088
1,22.1,Product leakage,,17137088
0,22.1,Prostatic specific antigen increased,3,17137090
0,22.1,Sluggishness,6,17137111
1,22.1,Fatigue,6,17137111
0,22.1,Prostatic specific antigen increased,6,17137115
0,22.1,Death,5,17137139
0,22.1,Death,5,17137141
0,22.1,Infection,6,17137142
0,22.1,Death,5,17137143
0,22.1,Death,5,17137145
0,22.1,Rash,6,17137147
1,22.1,Transient ischaemic attack,6,17137147
0,22.1,Hypertension,1,17137149
1,22.1,Retching,1,17137149
2,22.1,Stomatitis,6,17137149
3,22.1,Weight decreased,6,17137149
4,22.1,Decreased appetite,6,17137149
5,22.1,Death,5,17137149
6,22.1,Palmar-plantar erythrodysaesthesia syndrome,3,17137149
0,22.1,Deep vein thrombosis,2,17137161
0,22.1,Cardiac failure,2,17137176
0,22.1,Pelvic pain,6,17137180
1,22.1,Chest discomfort,6,17137180
2,22.1,Rash,6,17137180
0,22.1,Anaphylactic shock,2,17137183
1,22.1,Neuropathy peripheral,2,17137183
0,22.1,Death,5,17137186
0,22.1,Death,5,17137188
0,22.1,Bone marrow failure,6,17137191
1,22.1,Neoplasm progression,6,17137191
2,22.1,Fatigue,3,17137191
3,22.1,Urinary tract infection,1,17137191
0,22.1,Muscular weakness,3,17137245
1,22.1,Incorrect route of product administration,6,17137245
0,22.1,Hyperpyrexia,2,17137254
1,22.1,Feeling cold,2,17137254
0,22.1,Death,5,17137268
0,22.1,Death,5,17137269
0,22.1,Death,5,17137270
0,22.1,Stomatitis,6,17137289
1,22.1,Hair texture abnormal,6,17137289
0,22.1,Polyneuropathy,6,17137329
1,22.1,Pruritus,6,17137329
2,22.1,Gastrointestinal disorder,6,17137329
3,22.1,Dacryostenosis acquired,6,17137329
4,22.1,Hot flush,6,17137329
0,22.1,Malaise,6,17137333
1,22.1,Metastatic neoplasm,5,17137333
0,22.1,Neurotoxicity,1,17137367
1,22.1,Dermatitis acneiform,1,17137367
2,22.1,Haematotoxicity,1,17137367
0,22.1,Retinal detachment,4,17137417
1,22.1,Necrotising retinitis,3,17137417
0,22.1,Antiphospholipid syndrome,5,17137459
1,22.1,Haemoptysis,6,17137459
2,22.1,Diffuse alveolar damage,5,17137459
3,22.1,Pulmonary alveolar haemorrhage,6,17137459
4,22.1,Haematuria,6,17137459
0,22.1,Thrombocytopenia,3,17137475
1,22.1,Febrile neutropenia,3,17137475
0,22.1,Pigmentation disorder,3,17137506
1,22.1,Paronychia,3,17137506
2,22.1,Deep vein thrombosis,2,17137506
3,22.1,Pulmonary embolism,2,17137506
4,22.1,Neutropenia,3,17137506
0,22.1,Peripheral ischaemia,1,17137523
0,22.1,Bone marrow failure,1,17137535
0,22.1,Bone marrow failure,1,17137540
0,22.1,Product use in unapproved indication,6,17137549
1,22.1,Neoplasm progression,6,17137549
2,22.1,Off label use,6,17137549
0,22.1,Cerebral infarction,1,17137573
1,22.1,Pneumonia,1,17137573
0,22.1,Diabetic ketoacidosis,1,17137579
1,22.1,Type 1 diabetes mellitus,6,17137579
0,22.1,Acute kidney injury,1,17137611
1,22.1,Diarrhoea,1,17137611
2,22.1,Hypovolaemic shock,1,17137611
0,22.1,Chronic kidney disease,6,17137664
1,22.1,Off label use,6,17137664
2,22.1,Intentional product use issue,6,17137664
0,22.1,Pyrexia,1,17137700
0,22.1,Hypokalaemia,1,17137704
0,22.1,Febrile neutropenia,1,17137734
0,22.1,Pneumonia aspiration,6,17137766
0,22.1,Breast cancer metastatic,6,17137777
1,22.1,Disease progression,6,17137777
2,22.1,Acute lymphocytic leukaemia,6,17137777
3,22.1,Malignant neoplasm progression,6,17137777
4,22.1,Breast cancer recurrent,6,17137777
5,22.1,Second primary malignancy,6,17137777
0,22.1,Tendon rupture,1,17137788
0,22.1,Tetany,1,17137816
1,22.1,Hypomagnesaemia,2,17137816
2,22.1,Hypocalcaemia,1,17137816
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,1,17137827
0,22.1,Electrocardiogram QT prolonged,1,17137910
0,22.1,Cerebral infarction,1,17137927
0,22.1,Off label use,6,17137936
1,22.1,Intentional product use issue,6,17137936
2,22.1,Pigmentation disorder,2,17137936
3,22.1,Skin disorder,2,17137936
4,22.1,Skin fissures,2,17137936
0,22.1,Metastases to spine,3,17137957
1,22.1,Prostatic specific antigen increased,3,17137957
0,22.1,Thyrotoxic crisis,6,17138008
0,22.1,Malignant neoplasm progression,3,17138024
1,22.1,Peripheral swelling,3,17138024
2,22.1,Fatigue,3,17138024
0,22.1,Cardiac dysfunction,6,17138060
0,22.1,Malignant neoplasm progression,6,17138065
1,22.1,Metastases to bone,6,17138065
2,22.1,Metastases to liver,6,17138065
3,22.1,Breast cancer,6,17138065
0,22.1,Paraneoplastic arthritis,2,17138066
1,22.1,Electrocardiogram QT prolonged,2,17138066
0,22.1,Rash,1,17138085
1,22.1,Skin toxicity,1,17138085
0,22.1,Tremor,1,17138103
1,22.1,Oxygen saturation decreased,1,17138103
2,22.1,Hypotension,1,17138103
3,22.1,Agitation,1,17138103
0,22.1,Feeling hot,1,17138104
1,22.1,Dyspnoea,1,17138104
2,22.1,Chest pain,1,17138104
3,22.1,Flushing,1,17138104
4,22.1,Drug hypersensitivity,1,17138104
0,22.1,Cerebral infarction,5,17138122
0,22.1,Chest discomfort,2,17138124
1,22.1,Tachypnoea,2,17138124
2,22.1,White blood cell count decreased,2,17138124
3,22.1,Palpitations,2,17138124
4,22.1,Dizziness,2,17138124
0,22.1,Stomatitis,2,17138129
0,22.1,Dementia,6,17138210
0,22.1,Administration site extravasation,3,17138239
1,22.1,Skin necrosis,3,17138239
2,22.1,Erythema,3,17138239
0,22.1,Skin toxicity,1,17138240
1,22.1,Gastrointestinal toxicity,1,17138240
0,22.1,Hospitalisation,,17138319
0,22.1,Disease progression,,17138406
0,22.1,Disease progression,,17138487
0,22.1,Pulmonary embolism,6,17138609
1,22.1,Aortic thrombosis,6,17138609
2,22.1,Deep vein thrombosis,6,17138609
3,22.1,Myocardial infarction,6,17138609
0,22.1,Renal failure,3,17138817
1,22.1,Haemorrhagic stroke,3,17138817
2,22.1,Gastric haemorrhage,3,17138817
0,22.1,Death,,17138893
0,22.1,Death,,17138902
0,22.1,Death,,17139042
0,22.1,Death,,17139070
0,22.1,Death,,17139086
0,22.1,Syncope,2,17139102
1,22.1,Eczema,2,17139102
0,22.1,Hormone-refractory prostate cancer,5,17139119
0,22.1,Hepatic cancer,,17139159
0,22.1,Post procedural haemorrhage,1,17139186
0,22.1,Rib fracture,,17139187
1,22.1,Fall,,17139187
2,22.1,Pain in extremity,,17139187
0,22.1,Dyspnoea,,17139191
0,22.1,Disease progression,,17139199
0,22.1,Death,5,17139203
0,22.1,Hospice care,,17139239
0,22.1,Intestinal obstruction,6,17139276
0,22.1,Nausea,2,17139295
1,22.1,Diarrhoea,2,17139295
2,22.1,Off label use,6,17139295
3,22.1,Pancytopenia,2,17139295
0,22.1,Thrombocytopenia,1,17139306
1,22.1,Neutropenia,1,17139306
2,22.1,Dyspnoea,2,17139306
3,22.1,Peripheral swelling,1,17139306
4,22.1,Pulmonary embolism,6,17139306
5,22.1,Deep vein thrombosis,2,17139306
6,22.1,Leukopenia,1,17139306
7,22.1,Inappropriate schedule of product administration,6,17139306
0,22.1,Sequestrectomy,1,17139375
1,22.1,Loose tooth,1,17139375
2,22.1,Tooth extraction,1,17139375
3,22.1,Osteonecrosis of jaw,6,17139375
0,22.1,Anaphylactic shock,1,17139377
0,22.1,Cardiac arrest,5,17139379
1,22.1,Off label use,6,17139379
0,22.1,Toxicity to various agents,6,17139411
1,22.1,Tachyphylaxis,6,17139411
2,22.1,Delirium,6,17139411
3,22.1,Confusional state,6,17139411
0,22.1,Pancreatitis acute,2,17139431
0,22.1,Death,,17139454
0,22.1,Pneumonia,1,17139467
0,22.1,Death,5,17139489
0,22.1,Breast disorder female,2,17139499
1,22.1,Pelvic pain,1,17139499
2,22.1,Vomiting,1,17139499
3,22.1,Somnolence,3,17139499
4,22.1,Cough,3,17139499
5,22.1,Muscle spasms,1,17139499
0,22.1,Pain,6,17139507
0,22.1,Vomiting,,17139531
1,22.1,Nausea,,17139531
0,22.1,Death,,17139536
0,22.1,Myocardial infarction,,17139539
1,22.1,Therapy cessation,,17139539
0,22.1,Death,5,17139541
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,17139543
1,22.1,Stomatitis,3,17139543
2,22.1,Decreased appetite,1,17139543
3,22.1,Pain,6,17139543
0,22.1,Product dose omission,6,17139548
1,22.1,Drug ineffective,6,17139548
2,22.1,Asthenia,6,17139548
3,22.1,Blood glucose increased,1,17139548
4,22.1,Dysgeusia,3,17139548
5,22.1,Diarrhoea,3,17139548
6,22.1,Recurrent cancer,6,17139548
7,22.1,Nausea,3,17139548
8,22.1,Product use in unapproved indication,6,17139548
0,22.1,Abdominal pain,1,17139581
0,22.1,Hepatic failure,1,17139584
1,22.1,Portal vein occlusion,1,17139584
2,22.1,Blood iron increased,2,17139584
0,22.1,Neutrophil count decreased,2,17139656
1,22.1,White blood cell count decreased,2,17139656
0,22.1,Platelet count decreased,1,17139661
1,22.1,Atelectasis,1,17139661
2,22.1,Disease progression,5,17139661
3,22.1,Dyspnoea,1,17139661
4,22.1,Muscular weakness,1,17139661
5,22.1,Encephalopathy,1,17139661
6,22.1,Fatigue,1,17139661
7,22.1,Anaemia,1,17139661
8,22.1,Dizziness,1,17139661
9,22.1,Pain,1,17139661
0,22.1,Atrial fibrillation,1,17139800
1,22.1,Cerebrovascular accident,1,17139800
0,22.1,Hypothyroidism,6,17139806
1,22.1,Enterocolitis,2,17139806
2,22.1,Hepatic function abnormal,2,17139806
3,22.1,Pancreatitis,2,17139806
4,22.1,Sjogren^s syndrome,2,17139806
5,22.1,Cholangitis,2,17139806
0,22.1,Neutropenia,5,17139840
1,22.1,Mucosal toxicity,5,17139840
2,22.1,Haematotoxicity,5,17139840
3,22.1,Leukopenia,5,17139840
4,22.1,Diarrhoea,5,17139840
5,22.1,Diarrhoea haemorrhagic,5,17139840
6,22.1,Colitis,5,17139840
0,22.1,Cardiac failure,2,17139841
1,22.1,Electrocardiogram abnormal,2,17139841
2,22.1,Dyspnoea,2,17139841
3,22.1,Exercise tolerance decreased,2,17139841
4,22.1,Orthopnoea,2,17139841
0,22.1,Drug interaction,6,17139842
1,22.1,Peripheral ischaemia,1,17139842
0,22.1,Asthenia,2,17139846
1,22.1,Liver injury,2,17139846
0,22.1,Colitis ulcerative,2,17139874
0,22.1,Cyanosis,1,17139877
1,22.1,Dyspnoea,1,17139877
2,22.1,Hypersensitivity,1,17139877
3,22.1,Back pain,1,17139877
4,22.1,Erythema,1,17139877
5,22.1,Off label use,6,17139877
0,22.1,Neoplasm malignant,6,17139880
0,22.1,Neutropenia,1,17139906
0,22.1,Rotavirus test positive,2,17139948
1,22.1,Respiratory syncytial virus test positive,1,17139948
2,22.1,Pneumonia,1,17139948
3,22.1,Pyrexia,2,17139948
4,22.1,Dehydration,2,17139948
5,22.1,Diarrhoea,6,17139948
0,22.1,Pain,6,17140189
0,22.1,Renal impairment,3,17140218
0,22.1,Thrombosis,3,17140244
1,22.1,Death,5,17140244
2,22.1,Multiple organ dysfunction syndrome,3,17140244
3,22.1,Pulmonary thrombosis,3,17140244
0,22.1,Atrioventricular block,6,17140512
0,22.1,Microangiopathic haemolytic anaemia,3,17140530
0,22.1,General physical health deterioration,1,17140550
1,22.1,Right atrial dilatation,4,17140550
2,22.1,Supraventricular tachycardia,6,17140550
3,22.1,Sinus arrhythmia,4,17140550
4,22.1,Tricuspid valve incompetence,4,17140550
5,22.1,Hypoaesthesia oral,3,17140550
6,22.1,Haemangioma of liver,6,17140550
7,22.1,Supraventricular extrasystoles,6,17140550
8,22.1,Pleural effusion,6,17140550
9,22.1,Pulmonary pain,3,17140550
10,22.1,Extrasystoles,4,17140550
11,22.1,Left ventricular dysfunction,4,17140550
0,22.1,Renal impairment,6,17140576
1,22.1,Urinary tract infection,6,17140576
0,22.1,Pulmonary embolism,1,17140614
0,22.1,Decreased appetite,6,17140618
1,22.1,Malignant neoplasm progression,6,17140618
2,22.1,Death,5,17140618
0,22.1,Pruritus,3,17140642
1,22.1,Hot flush,3,17140642
2,22.1,Tremor,3,17140642
3,22.1,Nausea,3,17140642
0,22.1,Blood alkaline phosphatase increased,6,17140662
1,22.1,Cholelithiasis,6,17140662
2,22.1,Concomitant disease aggravated,6,17140662
3,22.1,Nasopharyngitis,1,17140662
4,22.1,Drug-induced liver injury,1,17140662
5,22.1,Inguinal hernia,1,17140662
6,22.1,Hepatic steatosis,6,17140662
7,22.1,Liver function test abnormal,1,17140662
8,22.1,Blood bilirubin increased,6,17140662
9,22.1,Inguinal hernia,6,17140662
10,22.1,Ascites,6,17140662
11,22.1,Hepatic enzyme increased,1,17140662
12,22.1,Transaminases increased,6,17140662
0,22.1,Fatigue,3,17140682
0,22.1,Pyrexia,1,17140700
1,22.1,Diarrhoea,1,17140700
2,22.1,Malignant neoplasm progression,5,17140700
0,22.1,Hypersensitivity,6,17140748
1,22.1,Acute respiratory distress syndrome,1,17140748
0,22.1,Peripheral motor neuropathy,2,17140841
0,22.1,Pericarditis,6,17140860
0,22.1,Pyrexia,6,17140868
1,22.1,Drug reaction with eosinophilia and systemic symptoms,6,17140868
0,22.1,Platelet count decreased,3,17140896
1,22.1,Decreased appetite,3,17140896
2,22.1,Blood pressure increased,2,17140896
3,22.1,Stomatitis,3,17140896
4,22.1,Cough,3,17140896
5,22.1,Nausea,3,17140896
6,22.1,Oral pain,3,17140896
7,22.1,Fatigue,3,17140896
0,22.1,Chest pain,6,17140912
1,22.1,Tinnitus,6,17140912
2,22.1,Dyspnoea,6,17140912
3,22.1,Decreased appetite,6,17140912
4,22.1,Weight increased,6,17140912
5,22.1,Dry mouth,6,17140912
6,22.1,Pruritus,6,17140912
7,22.1,Vision blurred,6,17140912
8,22.1,Drug ineffective,6,17140912
9,22.1,Headache,6,17140912
10,22.1,Fatigue,6,17140912
11,22.1,Muscle spasms,6,17140912
12,22.1,Anxiety,6,17140912
13,22.1,Micturition urgency,6,17140912
14,22.1,Nausea,6,17140912
15,22.1,Malaise,6,17140912
16,22.1,Cough,6,17140912
17,22.1,Pulse abnormal,6,17140912
18,22.1,Bone pain,6,17140912
0,22.1,Ascites,6,17140927
1,22.1,Hepatic atrophy,6,17140927
2,22.1,Thrombocytopenia,1,17140927
0,22.1,Hepatotoxicity,2,17140935
1,22.1,Carbohydrate antigen 15-3 increased,6,17140935
2,22.1,Hepatotoxicity,1,17140935
3,22.1,Neutropenia,6,17140935
4,22.1,Neoplasm progression,6,17140935
5,22.1,Liver disorder,1,17140935
0,22.1,Therapeutic response unexpected,6,17140962
1,22.1,Pre-existing condition improved,6,17140962
2,22.1,White blood cell count decreased,3,17140962
0,22.1,Hair colour changes,3,17141000
1,22.1,Hair texture abnormal,3,17141000
2,22.1,Madarosis,3,17141000
3,22.1,Hair disorder,3,17141000
4,22.1,Alopecia,3,17141000
0,22.1,Alopecia,3,17141021
1,22.1,Madarosis,3,17141021
2,22.1,Hair colour changes,3,17141021
3,22.1,Hair texture abnormal,3,17141021
4,22.1,Hair disorder,3,17141021
0,22.1,Neoplasm progression,6,17141068
0,22.1,Change of bowel habit,6,17141096
1,22.1,Syncope,6,17141096
2,22.1,Paraesthesia,6,17141096
3,22.1,Platelet count decreased,3,17141096
4,22.1,Dyspepsia,6,17141096
5,22.1,Myalgia,6,17141096
6,22.1,Dizziness,6,17141096
7,22.1,White blood cell count decreased,2,17141096
8,22.1,Asthenia,6,17141096
9,22.1,Haemoglobin decreased,3,17141096
0,22.1,Fatigue,6,17141122
0,22.1,Alopecia,3,17141124
1,22.1,Hair disorder,3,17141124
2,22.1,Hair colour changes,3,17141124
3,22.1,Hair texture abnormal,3,17141124
0,22.1,Headache,6,17141126
0,22.1,Hypoacusis,6,17141131
0,22.1,Malaise,6,17141132
1,22.1,Eating disorder,6,17141132
2,22.1,Pulmonary mass,3,17141132
0,22.1,Hypotension,6,17141133
0,22.1,Madarosis,3,17141138
1,22.1,Alopecia,3,17141138
2,22.1,Hair texture abnormal,3,17141138
3,22.1,Hair colour changes,3,17141138
4,22.1,Hair disorder,3,17141138
0,22.1,Hair disorder,3,17141141
1,22.1,Hair colour changes,3,17141141
2,22.1,Alopecia,3,17141141
3,22.1,Hair texture abnormal,3,17141141
4,22.1,Madarosis,3,17141141
0,22.1,Dysphonia,6,17141149
1,22.1,Malaise,2,17141149
0,22.1,Hair texture abnormal,3,17141150
1,22.1,Madarosis,3,17141150
2,22.1,Alopecia,3,17141150
3,22.1,Hair colour changes,3,17141150
4,22.1,Hair disorder,3,17141150
0,22.1,Alopecia,3,17141151
1,22.1,Madarosis,3,17141151
2,22.1,Hair disorder,3,17141151
3,22.1,Hair colour changes,3,17141151
4,22.1,Hair texture abnormal,3,17141151
0,22.1,Hypoacusis,6,17141167
1,22.1,Malaise,6,17141167
0,22.1,Nervousness,6,17141172
0,22.1,Nasal congestion,6,17141174
1,22.1,Nasopharyngitis,1,17141174
2,22.1,Fatigue,6,17141174
3,22.1,Epistaxis,6,17141174
4,22.1,Skin disorder,6,17141174
5,22.1,Skin discolouration,6,17141174
0,22.1,Hair disorder,3,17141182
1,22.1,Hair texture abnormal,3,17141182
2,22.1,Alopecia,3,17141182
3,22.1,Madarosis,3,17141182
4,22.1,Hair colour changes,3,17141182
0,22.1,Alopecia,3,17141197
1,22.1,Madarosis,3,17141197
2,22.1,Hair disorder,6,17141197
3,22.1,Hair colour changes,6,17141197
4,22.1,Hair texture abnormal,6,17141197
0,22.1,Hypertension,6,17141223
1,22.1,Hypothyroidism,6,17141223
2,22.1,Pleural effusion,6,17141223
3,22.1,Lymphoedema,6,17141223
0,22.1,Loose tooth,1,17141241
1,22.1,Osteonecrosis of jaw,1,17141241
2,22.1,Osteonecrosis of jaw,6,17141241
0,22.1,Febrile neutropenia,1,17141251
0,22.1,Adverse event,6,17141291
0,22.1,Pruritus,2,17141298
1,22.1,Electrocardiogram QT prolonged,2,17141298
2,22.1,Oedema peripheral,2,17141298
0,22.1,Neoplasm progression,3,17141299
0,22.1,Off label use,6,17141317
1,22.1,Death,5,17141317
2,22.1,Product use issue,6,17141317
0,22.1,Generalised tonic-clonic seizure,3,17141329
0,22.1,Fall,2,17141339
1,22.1,Diplopia,2,17141339
2,22.1,Hypertensive crisis,2,17141339
3,22.1,Subarachnoid haemorrhage,2,17141339
4,22.1,Cerebral haemorrhage,2,17141339
5,22.1,Headache,2,17141339
0,22.1,Diarrhoea,1,17141350
0,22.1,Encephalopathy,1,17141370
1,22.1,Psychotic disorder,1,17141370
2,22.1,Delirium,1,17141370
3,22.1,Colitis,1,17141370
4,22.1,Suicidal ideation,1,17141370
0,22.1,Pulmonary arterial hypertension,6,17141374
1,22.1,Obliterative bronchiolitis,6,17141374
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,2,17141396
1,22.1,Hypothyroidism,2,17141396
2,22.1,Muscle discomfort,2,17141396
3,22.1,Hypertensive crisis,1,17141396
4,22.1,Asthenia,2,17141396
0,22.1,Death,5,17141424
0,22.1,Neutropenia,6,17141461
0,22.1,Thrombocytopenia,6,17141465
1,22.1,Neoplasm progression,6,17141465
2,22.1,Neutropenia,6,17141465
0,22.1,Incorrect route of product administration,6,17141505
1,22.1,Muscular weakness,3,17141505
0,22.1,Amniotic fluid index decreased,6,17141514
1,22.1,Exposure during pregnancy,1,17141514
2,22.1,Premature labour,1,17141514
3,22.1,Foetal hypokinesia,6,17141514
4,22.1,Haemoglobin decreased,6,17141514
0,22.1,Foetal exposure during pregnancy,1,17141515
0,22.1,Seroma,1,17141545
0,22.1,Emotional distress,6,17141547
1,22.1,Pain,6,17141547
2,22.1,Alopecia,3,17141547
3,22.1,Impaired quality of life,6,17141547
4,22.1,Psychological trauma,6,17141547
5,22.1,Anxiety,6,17141547
0,22.1,Alopecia,2,17141583
0,22.1,Alopecia,3,17141589
1,22.1,Psychological trauma,6,17141589
0,22.1,Anxiety,6,17141650
1,22.1,Psychological trauma,6,17141650
2,22.1,Alopecia,2,17141650
3,22.1,Pain,6,17141650
4,22.1,Impaired quality of life,6,17141650
5,22.1,Emotional distress,6,17141650
0,22.1,Hypotension,6,17141719
1,22.1,Asthenia,6,17141719
2,22.1,Balance disorder,6,17141719
3,22.1,Gait disturbance,6,17141719
4,22.1,Pyrexia,6,17141719
5,22.1,Malaise,6,17141719
0,22.1,Urinary tract infection,3,17141724
1,22.1,Anxiety,3,17141724
2,22.1,Back pain,3,17141724
3,22.1,Dry skin,3,17141724
4,22.1,Arthralgia,3,17141724
5,22.1,Haemoglobin decreased,6,17141724
6,22.1,Walking aid user,6,17141724
7,22.1,Intentional dose omission,3,17141724
8,22.1,Somnolence,3,17141724
9,22.1,Fatigue,3,17141724
0,22.1,Death,5,17141738
1,22.1,Thrombocytopenia,6,17141738
0,22.1,Death,5,17141748
0,22.1,Cognitive disorder,6,17141764
1,22.1,Osteonecrosis of jaw,6,17141764
2,22.1,Asthenia,6,17141764
3,22.1,Malignant neoplasm progression,6,17141764
4,22.1,Prostatic specific antigen increased,6,17141764
0,22.1,Death,5,17141769
0,22.1,Prinzmetal angina,1,17141791
0,22.1,Prostate cancer,5,17141819
0,22.1,Product dose omission,6,17141822
1,22.1,Knee arthroplasty,6,17141822
2,22.1,Carbohydrate antigen 125 increased,3,17141822
3,22.1,Nausea,6,17141822
0,22.1,Taste disorder,3,17141859
1,22.1,Thirst,3,17141859
2,22.1,Colon cancer,5,17141859
3,22.1,Hallucination,3,17141859
0,22.1,Blood pressure decreased,6,17141877
1,22.1,Nausea,6,17141877
2,22.1,Vomiting,6,17141877
3,22.1,Thrombosis,5,17141877
4,22.1,Cardio-respiratory arrest,6,17141877
5,22.1,Hyperhidrosis,6,17141877
6,22.1,Feeling abnormal,6,17141877
0,22.1,Malignant neoplasm progression,5,17141879
0,22.1,Death,5,17141908
0,22.1,Upper respiratory tract infection,2,17141915
1,22.1,Nausea,6,17141915
0,22.1,Cardiac disorder,5,17141928
0,22.1,Prostate cancer,5,17141930
0,22.1,Cardiac disorder,6,17141977
0,22.1,Loss of consciousness,1,17141982
1,22.1,Dizziness,1,17141982
0,22.1,Malignant neoplasm progression,3,17141993
0,22.1,Prostate cancer metastatic,6,17142033
1,22.1,Somnolence,6,17142033
0,22.1,Pneumonitis,5,17142046
1,22.1,Haemorrhage,6,17142046
0,22.1,Pyrexia,2,17142052
1,22.1,Interstitial lung disease,2,17142052
0,22.1,Diarrhoea,3,17142060
1,22.1,Product label issue,6,17142060
0,22.1,Drug resistance,6,17142083
1,22.1,Malignant neoplasm progression,6,17142083
0,22.1,Drug resistance,6,17142088
1,22.1,Malignant neoplasm progression,6,17142088
0,22.1,Systemic lupus erythematosus,6,17142091
0,22.1,Liver disorder,2,17142114
0,22.1,Intentional product use issue,6,17142121
0,22.1,Epistaxis,3,17142135
0,22.1,Death,5,17142143
1,22.1,Neoplasm progression,6,17142143
0,22.1,Pancytopenia,6,17142153
0,22.1,Drug resistance,6,17142156
1,22.1,Asthenia,6,17142156
2,22.1,Weight decreased,6,17142156
3,22.1,Malignant neoplasm progression,6,17142156
4,22.1,Metastases to abdominal cavity,6,17142156
5,22.1,Nasopharyngitis,6,17142156
0,22.1,Death,5,17142161
0,22.1,Dry mouth,6,17142166
1,22.1,Liver function test abnormal,6,17142166
0,22.1,Confusional state,1,17142175
1,22.1,Product availability issue,6,17142175
2,22.1,Gait disturbance,1,17142175
3,22.1,Death,5,17142175
4,22.1,Ammonia increased,1,17142175
5,22.1,Therapy cessation,6,17142175
0,22.1,Diarrhoea,1,17142179
0,22.1,Back pain,1,17142214
0,22.1,Cold sweat,1,17142217
1,22.1,Dyskinesia,1,17142217
2,22.1,Stupor,1,17142217
3,22.1,Chills,1,17142217
0,22.1,Cold sweat,1,17142218
1,22.1,Chills,1,17142218
2,22.1,Dysarthria,1,17142218
3,22.1,Vision blurred,1,17142218
0,22.1,Anaphylactic shock,1,17142224
0,22.1,Hypoxia,6,17142241
1,22.1,Atrial fibrillation,6,17142241
2,22.1,Dyspnoea,6,17142241
3,22.1,Cardiac failure,6,17142241
0,22.1,Coronary artery disease,1,17142260
0,22.1,Skin fissures,3,17142321
1,22.1,Fatigue,1,17142321
2,22.1,Diarrhoea,3,17142321
3,22.1,Blister,3,17142321
4,22.1,Nausea,3,17142321
5,22.1,Chest pain,1,17142321
6,22.1,Oral mucosal blistering,1,17142321
7,22.1,Tongue blistering,1,17142321
8,22.1,Dyspepsia,1,17142321
9,22.1,Decreased appetite,3,17142321
10,22.1,Skin exfoliation,3,17142321
11,22.1,Headache,1,17142321
12,22.1,Asthenia,2,17142321
13,22.1,Blood glucose decreased,3,17142321
14,22.1,Hypertension,1,17142321
15,22.1,Weight decreased,3,17142321
0,22.1,Rash,6,17142330
1,22.1,Product use in unapproved indication,6,17142330
0,22.1,Breast cancer,6,17142335
1,22.1,Malignant neoplasm progression,6,17142335
2,22.1,Metastases to liver,6,17142335
0,22.1,Chronic obstructive pulmonary disease,2,17142364
0,22.1,Protein urine present,6,17142388
0,22.1,Nausea,6,17142414
1,22.1,Vomiting,6,17142414
0,22.1,Vomiting,6,17142416
1,22.1,Headache,6,17142416
2,22.1,Nausea,6,17142416
3,22.1,Abdominal pain,6,17142416
0,22.1,Mucosal inflammation,6,17142417
0,22.1,Oral pain,6,17142446
1,22.1,Vomiting,6,17142446
2,22.1,Constipation,6,17142446
3,22.1,Dehydration,6,17142446
4,22.1,Headache,6,17142446
5,22.1,Haemorrhage,6,17142446
6,22.1,Sleep disorder,6,17142446
7,22.1,Retching,6,17142446
8,22.1,Blood pressure systolic,1,17142446
9,22.1,Anaemia,6,17142446
10,22.1,Fatigue,6,17142446
11,22.1,Ulcer haemorrhage,6,17142446
12,22.1,Nausea,6,17142446
0,22.1,Oedema peripheral,6,17142513
0,22.1,Off label use,6,17142514
1,22.1,Intentional product use issue,6,17142514
2,22.1,Ataxia,3,17142514
0,22.1,Hepatic enzyme increased,1,17142520
0,22.1,Taste disorder,3,17142522
1,22.1,Paraesthesia,3,17142522
2,22.1,Dizziness,2,17142522
3,22.1,Feeling drunk,2,17142522
0,22.1,Hair disorder,3,17142601
1,22.1,Hair colour changes,3,17142601
2,22.1,Hair texture abnormal,3,17142601
3,22.1,Alopecia,3,17142601
0,22.1,Hair texture abnormal,3,17142604
1,22.1,Hair colour changes,3,17142604
2,22.1,Madarosis,3,17142604
3,22.1,Hair disorder,3,17142604
4,22.1,Alopecia,3,17142604
0,22.1,Encephalitis,2,17142621
0,22.1,Stomatitis,6,17142627
1,22.1,Epistaxis,6,17142627
2,22.1,Haematochezia,6,17142627
3,22.1,Asthenia,6,17142627
0,22.1,Syncope,1,17142636
0,22.1,Basal cell carcinoma,3,17142640
0,22.1,Adverse drug reaction,6,17142680
1,22.1,Drug ineffective,6,17142680
0,22.1,Thrombosis,6,17142693
0,22.1,Pleural effusion,3,17142810
1,22.1,Ascites,3,17142810
2,22.1,Generalised oedema,3,17142810
0,22.1,Loss of consciousness,1,17142855
0,22.1,Mucosal inflammation,1,17142876
1,22.1,White blood cell count decreased,1,17142876
2,22.1,Off label use,6,17142876
0,22.1,Fatigue,6,17142937
1,22.1,Vomiting,6,17142937
2,22.1,Diarrhoea,6,17142937
3,22.1,Nausea,6,17142937
0,22.1,Pleural neoplasm,6,17143021
1,22.1,Breast cancer recurrent,6,17143021
2,22.1,Therapeutic product effect incomplete,6,17143021
3,22.1,Metastases to liver,6,17143021
4,22.1,Metastases to lung,6,17143021
5,22.1,Malignant neoplasm progression,6,17143021
0,22.1,Flushing,1,17143051
1,22.1,Oxygen saturation decreased,1,17143051
2,22.1,Erythema,1,17143051
3,22.1,Respiratory failure,1,17143051
4,22.1,Infusion related reaction,1,17143051
5,22.1,Chest discomfort,1,17143051
0,22.1,Malaise,6,17143088
1,22.1,Product dose omission,6,17143088
0,22.1,Sinusitis,3,17143092
1,22.1,Paraesthesia,3,17143092
2,22.1,Malaise,3,17143092
3,22.1,Abdominal discomfort,3,17143092
4,22.1,Occipital neuralgia,3,17143092
5,22.1,Arthropod bite,3,17143092
6,22.1,Peripheral swelling,3,17143092
7,22.1,Tinnitus,3,17143092
8,22.1,Pancreatic atrophy,3,17143092
9,22.1,Blood sodium decreased,3,17143092
10,22.1,Nausea,3,17143092
11,22.1,Polyp,3,17143092
12,22.1,Heart rate increased,3,17143092
13,22.1,Palpitations,3,17143092
14,22.1,Arteriosclerosis coronary artery,3,17143092
15,22.1,Back pain,3,17143092
16,22.1,Arthralgia,3,17143092
17,22.1,Influenza,1,17143092
18,22.1,Flatulence,3,17143092
19,22.1,Muscle spasms,3,17143092
20,22.1,Immunosuppression,3,17143092
21,22.1,Osteoarthritis,3,17143092
22,22.1,Metastases to bone,3,17143092
23,22.1,Muscular weakness,3,17143092
24,22.1,Contusion,2,17143092
25,22.1,Malignant neoplasm progression,6,17143092
26,22.1,Sinus congestion,3,17143092
27,22.1,Dyspnoea,3,17143092
28,22.1,Cataract,3,17143092
29,22.1,Dyspepsia,1,17143092
30,22.1,Neck pain,2,17143092
31,22.1,Proteinuria,3,17143092
32,22.1,Fatigue,3,17143092
33,22.1,Respiratory tract infection,3,17143092
34,22.1,Asthenia,3,17143092
35,22.1,Pruritus,3,17143092
36,22.1,Depression,3,17143092
37,22.1,Hyponatraemia,3,17143092
38,22.1,Tendon injury,6,17143092
39,22.1,Swelling face,3,17143092
40,22.1,Epistaxis,3,17143092
41,22.1,Cyst,6,17143092
42,22.1,Hyperkeratosis,3,17143092
43,22.1,Dental caries,3,17143092
44,22.1,Pyrexia,2,17143092
45,22.1,Alopecia,6,17143092
46,22.1,Blood glucose fluctuation,3,17143092
47,22.1,Rash,3,17143092
48,22.1,Blood potassium increased,3,17143092
49,22.1,Abdominal pain upper,6,17143092
50,22.1,Insomnia,3,17143092
51,22.1,Migraine,3,17143092
52,22.1,Oropharyngeal pain,3,17143092
53,22.1,Anxiety,3,17143092
54,22.1,Abdominal distension,3,17143092
55,22.1,Gingival disorder,3,17143092
56,22.1,Ear discomfort,6,17143092
57,22.1,Chills,2,17143092
58,22.1,Pain,2,17143092
59,22.1,Body temperature fluctuation,3,17143092
60,22.1,Blister,3,17143092
61,22.1,Extrasystoles,3,17143092
62,22.1,Depression,3,17143092
63,22.1,Burning sensation,3,17143092
64,22.1,Hypertension,6,17143092
65,22.1,Pain in extremity,3,17143092
66,22.1,Acne,3,17143092
67,22.1,Weight decreased,2,17143092
68,22.1,Post procedural complication,6,17143092
69,22.1,Dysphonia,3,17143092
70,22.1,Upper-airway cough syndrome,3,17143092
71,22.1,Lymphadenopathy,3,17143092
72,22.1,Sinus disorder,3,17143092
73,22.1,Blood cholesterol increased,6,17143092
0,22.1,Weight decreased,6,17143172
1,22.1,Decreased appetite,6,17143172
2,22.1,Alopecia,6,17143172
3,22.1,Nausea,6,17143172
0,22.1,Red blood cell count decreased,,17143225
0,22.1,Second primary malignancy,5,17143228
1,22.1,Acute myeloid leukaemia,5,17143228
2,22.1,Cardiotoxicity,5,17143228
3,22.1,Cardiac arrest,5,17143228
0,22.1,Post procedural haemorrhage,1,17143230
1,22.1,Off label use,6,17143230
0,22.1,Subacute cutaneous lupus erythematosus,6,17143301
1,22.1,Skin lesion,6,17143301
2,22.1,Erythema,6,17143301
3,22.1,Rash,6,17143301
4,22.1,Dermatitis,6,17143301
5,22.1,Epidermal necrosis,6,17143301
0,22.1,Critical illness,6,17143353
0,22.1,Malnutrition,1,17143359
1,22.1,Dehydration,1,17143359
2,22.1,Diarrhoea,1,17143359
0,22.1,Anaphylactoid shock,1,17143395
0,22.1,Hypersensitivity,2,17143410
0,22.1,Anaphylactic reaction,1,17143411
0,22.1,Large intestine perforation,4,17143509
1,22.1,General physical health deterioration,1,17143509
0,22.1,Death,5,17143539
0,22.1,Fatigue,6,17143578
0,22.1,Drug interaction,3,17143586
1,22.1,Diarrhoea,3,17143586
2,22.1,Hypertension,3,17143586
3,22.1,Dry skin,3,17143586
4,22.1,Fatigue,3,17143586
5,22.1,Oral discomfort,3,17143586
6,22.1,Rash,1,17143586
7,22.1,Pruritus,1,17143586
0,22.1,Vomiting,6,17143598
1,22.1,Abdominal distension,6,17143598
2,22.1,Nausea,6,17143598
0,22.1,Neutropenia,6,17143632
1,22.1,Neoplasm progression,6,17143632
0,22.1,Pain,6,17143656
1,22.1,Blood pressure increased,6,17143656
2,22.1,Fatigue,6,17143656
3,22.1,Migraine with aura,6,17143656
4,22.1,Dyspepsia,6,17143656
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,17143689
1,22.1,Upper-airway cough syndrome,6,17143689
2,22.1,Anaemia,6,17143689
3,22.1,Neutropenia,6,17143689
0,22.1,Neutropenia,6,17143733
0,22.1,Myalgia,3,17143763
1,22.1,Neuropathy peripheral,3,17143763
2,22.1,Bone pain,3,17143763
0,22.1,Depersonalisation/derealisation disorder,1,17143827
1,22.1,Mobility decreased,3,17143827
2,22.1,Dysstasia,3,17143827
3,22.1,Depressed mood,1,17143827
0,22.1,Asthenia,1,17143888
1,22.1,Pyrexia,1,17143888
2,22.1,Syncope,1,17143888
3,22.1,Anaemia,1,17143888
0,22.1,Death,5,17143894
0,22.1,Neutropenia,1,17143895
1,22.1,Urinary tract infection,3,17143895
0,22.1,Colitis,1,17143910
0,22.1,Pruritus,1,17144013
1,22.1,Nausea,1,17144013
2,22.1,Gastrooesophageal reflux disease,1,17144013
3,22.1,Flushing,1,17144013
0,22.1,Pain,1,17144019
0,22.1,Large intestine perforation,4,17144023
1,22.1,General physical health deterioration,1,17144023
0,22.1,Photosensitivity reaction,1,17144031
0,22.1,Lethargy,6,17144078
1,22.1,Pain,6,17144078
2,22.1,Road traffic accident,6,17144078
0,22.1,Cough,3,17144098
1,22.1,Multiple organ dysfunction syndrome,5,17144098
2,22.1,Dyspnoea,3,17144098
3,22.1,Breast cancer metastatic,5,17144098
4,22.1,Malignant neoplasm progression,5,17144098
5,22.1,Emphysema,1,17144098
6,22.1,Femoral neck fracture,3,17144098
7,22.1,Back pain,1,17144098
0,22.1,Death,,17144104
0,22.1,Hepatic function abnormal,3,17144137
1,22.1,Drug ineffective,3,17144137
2,22.1,Disease progression,3,17144137
0,22.1,Metastatic lymphoma,2,17144151
1,22.1,Drug ineffective,3,17144151
2,22.1,Liver disorder,3,17144151
0,22.1,Electrocardiogram QT prolonged,6,17144156
0,22.1,Neuropathy peripheral,6,17144164
0,22.1,Death,5,17144185
0,22.1,Fall,6,17144186
1,22.1,Temperature regulation disorder,6,17144186
2,22.1,Dizziness,6,17144186
3,22.1,Oropharyngeal pain,6,17144186
4,22.1,Vomiting,6,17144186
5,22.1,Cough,6,17144186
6,22.1,Influenza,6,17144186
7,22.1,Pruritus,6,17144186
8,22.1,Blood pressure abnormal,6,17144186
0,22.1,Death,,17144202
0,22.1,Aphasia,2,17144215
1,22.1,Cerebrovascular accident,6,17144215
0,22.1,Death,5,17144217
0,22.1,Visual impairment,1,17144221
1,22.1,Hypotension,1,17144221
2,22.1,Rash,1,17144221
3,22.1,Oxygen saturation decreased,1,17144221
4,22.1,Pruritus,1,17144221
0,22.1,Transient ischaemic attack,1,17144222
0,22.1,Faecaloma,6,17144234
0,22.1,Headache,,17144238
0,22.1,Hypotension,1,17144245
1,22.1,Fall,1,17144245
0,22.1,Hereditary motor and sensory neuropathy,2,17144285
1,22.1,Condition aggravated,2,17144285
0,22.1,Cerebrovascular disorder,6,17144288
1,22.1,Gliosis,6,17144288
2,22.1,Weight decreased,6,17144288
3,22.1,Prostatic specific antigen increased,6,17144288
4,22.1,Myopia,6,17144288
5,22.1,Hypoaesthesia,6,17144288
6,22.1,Headache,6,17144288
7,22.1,Chest pain,6,17144288
8,22.1,Fatigue,6,17144288
9,22.1,Bone pain,6,17144288
10,22.1,Insomnia,6,17144288
11,22.1,Treatment noncompliance,6,17144288
0,22.1,Hypopharyngeal cancer,5,17144294
1,22.1,Melaena,5,17144294
2,22.1,Neutropenia,6,17144294
3,22.1,Pyrexia,5,17144294
4,22.1,Malignant neoplasm progression,5,17144294
5,22.1,Shock haemorrhagic,5,17144294
6,22.1,Staphylococcal sepsis,5,17144294
0,22.1,Death,5,17144353
0,22.1,Toothache,6,17144354
1,22.1,Oral pain,6,17144354
2,22.1,White blood cell count decreased,6,17144354
0,22.1,Neutropenia,1,17144357
1,22.1,Death,5,17144357
0,22.1,Malignant neoplasm progression,6,17144368
1,22.1,Pharyngeal fistula,5,17144368
2,22.1,Anaplastic thyroid cancer,6,17144368
0,22.1,Anaemia,6,17144377
0,22.1,Hair texture abnormal,6,17144386
1,22.1,Hair disorder,6,17144386
2,22.1,Hair colour changes,6,17144386
3,22.1,Madarosis,3,17144386
4,22.1,Depression,6,17144386
5,22.1,Alopecia,3,17144386
6,22.1,Anxiety,6,17144386
0,22.1,Death,5,17144396
0,22.1,Neoplasm malignant,6,17144409
1,22.1,Spinal compression fracture,6,17144409
2,22.1,Back pain,6,17144409
0,22.1,Headache,6,17144418
1,22.1,Nausea,6,17144418
2,22.1,Product dose omission,6,17144418
0,22.1,Fatigue,6,17144433
1,22.1,Tremor,6,17144433
2,22.1,Blood pressure increased,6,17144433
3,22.1,Palpitations,6,17144433
4,22.1,Constipation,6,17144433
5,22.1,Weight increased,6,17144433
0,22.1,Memory impairment,3,17144458
0,22.1,Vomiting,4,17144472
1,22.1,Pyrexia,4,17144472
2,22.1,Post procedural inflammation,4,17144472
0,22.1,Flushing,2,17144479
1,22.1,Palpitations,2,17144479
0,22.1,Pyrexia,6,17144496
1,22.1,Malaise,6,17144496
2,22.1,Vomiting,6,17144496
3,22.1,Diarrhoea,6,17144496
4,22.1,Gastroenteritis,6,17144496
5,22.1,Hypersensitivity,6,17144496
6,22.1,Abdominal pain,6,17144496
0,22.1,Atrial fibrillation,3,17144498
0,22.1,Neoplasm progression,5,17144503
0,22.1,Granulocytopenia,2,17144548
0,22.1,Free prostate-specific antigen increased,6,17144553
1,22.1,Chest pain,6,17144553
2,22.1,Metastases to bone,6,17144553
0,22.1,Neoplasm progression,5,17144560
1,22.1,Herpes zoster,6,17144560
2,22.1,Weight decreased,6,17144560
3,22.1,Pneumonia,2,17144560
4,22.1,Taste disorder,6,17144560
5,22.1,Hypophagia,6,17144560
0,22.1,Atrophy,1,17144565
1,22.1,Muscular weakness,1,17144565
2,22.1,Balance disorder,1,17144565
3,22.1,Hereditary motor and sensory neuropathy,6,17144565
4,22.1,Hypoaesthesia,1,17144565
5,22.1,Peripheral sensory neuropathy,1,17144565
6,22.1,Areflexia,1,17144565
7,22.1,Blood creatine phosphokinase increased,6,17144565
8,22.1,Myalgia,1,17144565
9,22.1,Hyporeflexia,1,17144565
0,22.1,Anal fistula,6,17144615
0,22.1,Epilepsy,6,17144661
1,22.1,Confusional state,6,17144661
2,22.1,Hyponatraemia,1,17144661
0,22.1,Ovarian germ cell teratoma stage I,1,17144702
0,22.1,Death,5,17144706
0,22.1,Diarrhoea,2,17144809
1,22.1,Sepsis,5,17144809
2,22.1,Acute kidney injury,5,17144809
3,22.1,Vomiting,2,17144809
0,22.1,Hypersensitivity,1,17144828
0,22.1,Hepatocellular injury,3,17144842
0,22.1,Memory impairment,6,17144861
1,22.1,Disease progression,6,17144861
2,22.1,Off label use,6,17144861
3,22.1,Hospitalisation,6,17144861
4,22.1,Confusional state,6,17144861
5,22.1,Neoplasm progression,6,17144861
0,22.1,Appendicitis,,17145012
0,22.1,Cardiovascular disorder,6,17145078
1,22.1,Electrocardiogram change,1,17145078
2,22.1,Electrocardiogram abnormal,6,17145078
3,22.1,Tachycardia,1,17145078
4,22.1,Pruritus,1,17145078
5,22.1,Hyperhidrosis,6,17145078
6,22.1,Infusion related reaction,6,17145078
0,22.1,Alopecia,2,17145096
0,22.1,Psychological trauma,6,17145129
1,22.1,Alopecia,2,17145129
2,22.1,Pain,6,17145129
3,22.1,Impaired quality of life,6,17145129
4,22.1,Anxiety,6,17145129
5,22.1,Emotional distress,6,17145129
0,22.1,Arteriospasm coronary,1,17145134
1,22.1,Myocardial ischaemia,1,17145134
0,22.1,Toxicity to various agents,6,17145137
0,22.1,Facial paresis,6,17145159
1,22.1,Back pain,6,17145159
2,22.1,Muscular weakness,6,17145159
3,22.1,Neck pain,6,17145159
4,22.1,Facial pain,6,17145159
0,22.1,Myocardial ischaemia,6,17145164
1,22.1,Arteriospasm coronary,6,17145164
0,22.1,Malignant neoplasm progression,6,17145168
0,22.1,Anaemia,,17145207
0,22.1,Pyrexia,,17145227
1,22.1,Syncope,,17145227
2,22.1,Dyspnoea,,17145227
3,22.1,Cough,,17145227
4,22.1,Oedema,,17145227
5,22.1,Pleural effusion,,17145227
6,22.1,Disease complication,,17145227
0,22.1,Anaemia,2,17145274
1,22.1,Neutropenia,1,17145274
2,22.1,Thrombocytopenia,1,17145274
3,22.1,Alopecia,1,17145274
0,22.1,Back pain,1,17145278
1,22.1,Rash,1,17145278
2,22.1,Hypertensive crisis,1,17145278
0,22.1,Disease progression,,17145381
0,22.1,Liver disorder,5,17145418
1,22.1,General physical health deterioration,5,17145418
0,22.1,Oculomucocutaneous syndrome,2,17145445
0,22.1,Mucosal inflammation,6,17145447
1,22.1,Disease progression,6,17145447
2,22.1,Neurotoxicity,3,17145447
3,22.1,Rash,6,17145447
0,22.1,Skin mass,,17145476
1,22.1,Neoplasm malignant,,17145476
0,22.1,Death,,17145478
0,22.1,Malignant neoplasm progression,6,17145479
0,22.1,Headache,6,17145486
1,22.1,Malignant neoplasm progression,6,17145486
2,22.1,Drug resistance,6,17145486
0,22.1,Disease progression,,17145497
0,22.1,Interstitial lung disease,5,17145527
1,22.1,Drug ineffective,6,17145527
0,22.1,Leukopenia,6,17145531
1,22.1,Respiratory fatigue,6,17145531
2,22.1,Erythema,6,17145531
3,22.1,Anaemia,6,17145531
4,22.1,Asthenia,6,17145531
0,22.1,Dialysis,6,17145545
1,22.1,Cardiac disorder,1,17145545
0,22.1,Drug resistance,6,17145555
1,22.1,Drug ineffective,6,17145555
0,22.1,Reproductive toxicity,6,17145562
1,22.1,Urinary tract toxicity,6,17145562
0,22.1,Malignant neoplasm progression,6,17145567
0,22.1,Urinary tract toxicity,6,17145569
1,22.1,Reproductive toxicity,6,17145569
0,22.1,Metastasis,6,17145570
1,22.1,Drug resistance,6,17145570
2,22.1,Infection,1,17145570
3,22.1,Malignant neoplasm progression,6,17145570
4,22.1,Pulmonary oedema,6,17145570
0,22.1,Cholelithiasis,1,17145585
0,22.1,Neutropenia,1,17145628
0,22.1,Malignant neoplasm progression,6,17145639
1,22.1,Metastases to bone,6,17145639
2,22.1,Off label use,6,17145639
3,22.1,Dysuria,6,17145639
4,22.1,Diarrhoea,6,17145639
5,22.1,Inappropriate schedule of product administration,6,17145639
6,22.1,Dizziness,3,17145639
7,22.1,Arthralgia,3,17145639
8,22.1,Urinary tract infection,6,17145639
9,22.1,Back pain,3,17145639
0,22.1,Pleural effusion,6,17145661
0,22.1,Maternal exposure during pregnancy,5,17145666
1,22.1,Cerebral haemorrhage neonatal,5,17145666
0,22.1,Neutropenia,6,17145673
1,22.1,Fatigue,6,17145673
2,22.1,Asthenia,6,17145673
3,22.1,Malignant neoplasm progression,6,17145673
4,22.1,Tumour marker increased,6,17145673
5,22.1,Pain,6,17145673
6,22.1,Breast cancer metastatic,6,17145673
0,22.1,Neutropenia,1,17145714
0,22.1,Ulcerative keratitis,1,17145729
1,22.1,Herpes ophthalmic,1,17145729
0,22.1,Cataract,3,17145740
0,22.1,Malignant neoplasm progression,6,17145744
0,22.1,Neutrophil count decreased,6,17145745
1,22.1,Radiation pneumonitis,2,17145745
0,22.1,Hypertension,1,17145788
1,22.1,Chills,1,17145788
0,22.1,Muscle spasms,6,17145792
0,22.1,Malignant transformation,6,17145793
1,22.1,Small cell lung cancer,6,17145793
2,22.1,Pleural effusion,6,17145793
3,22.1,Drug resistance,6,17145793
0,22.1,Malignant neoplasm progression,6,17145801
0,22.1,Pyrexia,1,17145805
1,22.1,Erythema,1,17145805
2,22.1,Swollen tongue,1,17145805
3,22.1,Rash,1,17145805
0,22.1,Cognitive disorder,2,17145809
0,22.1,Malignant neoplasm progression,6,17145839
0,22.1,Malignant neoplasm progression,6,17145840
0,22.1,Brain cancer metastatic,6,17145863
1,22.1,Cerebral disorder,5,17145863
0,22.1,Alopecia,3,17145923
1,22.1,Psychological trauma,6,17145923
0,22.1,Alopecia,3,17145945
1,22.1,Anxiety,6,17145945
2,22.1,Impaired quality of life,6,17145945
3,22.1,Pain,6,17145945
4,22.1,Emotional distress,6,17145945
5,22.1,Psychological trauma,6,17145945
0,22.1,Emotional distress,6,17145949
1,22.1,Impaired quality of life,6,17145949
2,22.1,Psychological trauma,6,17145949
3,22.1,Alopecia,2,17145949
4,22.1,Pain,6,17145949
5,22.1,Anxiety,6,17145949
0,22.1,Alopecia,2,17145952
0,22.1,Red blood cell count decreased,6,17145997
1,22.1,Haemoptysis,1,17145997
2,22.1,Malignant neoplasm progression,6,17145997
3,22.1,Drug resistance,6,17145997
4,22.1,Pyrexia,6,17145997
5,22.1,Haemoglobin decreased,6,17145997
6,22.1,Platelet count decreased,6,17145997
7,22.1,White blood cell count decreased,6,17145997
0,22.1,Febrile neutropenia,1,17146001
0,22.1,Acute generalised exanthematous pustulosis,1,17146006
0,22.1,Drug resistance,6,17146028
0,22.1,Muscle spasms,6,17146034
0,22.1,Drug interaction,6,17146042
1,22.1,Drug level decreased,6,17146042
0,22.1,Lung disorder,6,17146097
0,22.1,Malignant neoplasm progression,6,17146104
0,22.1,Neoplasm progression,6,17146108
1,22.1,Malignant neoplasm progression,6,17146108
2,22.1,Drug resistance,6,17146108
0,22.1,Malignant neoplasm progression,6,17146114
0,22.1,Bone marrow failure,2,17146133
0,22.1,Dyspnoea,6,17146201
1,22.1,Neurotoxicity,6,17146201
0,22.1,Lymphangiosis carcinomatosa,3,17146205
1,22.1,Interstitial lung disease,5,17146205
0,22.1,Off label use,6,17146215
1,22.1,Acute respiratory distress syndrome,5,17146215
2,22.1,Malaise,5,17146215
3,22.1,Multiple organ dysfunction syndrome,5,17146215
4,22.1,Pulmonary embolism,5,17146215
0,22.1,Disease progression,2,17146242
1,22.1,Therapy non-responder,6,17146242
0,22.1,Intentional dose omission,6,17146252
1,22.1,Squamous cell carcinoma,6,17146252
2,22.1,Blood pressure decreased,6,17146252
3,22.1,Asthenia,6,17146252
4,22.1,Inappropriate schedule of product administration,6,17146252
0,22.1,Disease progression,6,17146298
0,22.1,Metaplasia,1,17146310
1,22.1,Dermatitis,1,17146310
0,22.1,Neuropathy peripheral,2,17146347
1,22.1,Anaphylactic shock,2,17146347
0,22.1,Myocarditis,6,17146349
1,22.1,Ejection fraction decreased,2,17146349
0,22.1,Malignant neoplasm progression,6,17146351
0,22.1,Thrombosis,6,17146352
1,22.1,Dysgeusia,6,17146352
2,22.1,Nausea,2,17146352
3,22.1,Fatigue,3,17146352
0,22.1,Haemorrhage,1,17146414
1,22.1,Parotid gland enlargement,2,17146414
2,22.1,Wound secretion,6,17146414
3,22.1,Pain in jaw,6,17146414
4,22.1,Dysphagia,3,17146414
5,22.1,Transfusion,6,17146414
6,22.1,Head injury,6,17146414
7,22.1,Drug ineffective,6,17146414
8,22.1,Inappropriate schedule of product administration,6,17146414
9,22.1,Salivary gland neoplasm,3,17146414
0,22.1,Polyneuropathy in malignant disease,3,17146438
1,22.1,Intervertebral discitis,1,17146438
2,22.1,Myalgia,3,17146438
3,22.1,Off label use,6,17146438
4,22.1,Product use in unapproved indication,6,17146438
5,22.1,Therapy partial responder,6,17146438
0,22.1,Drug resistance,3,17146473
1,22.1,Eczema,1,17146473
2,22.1,Malignant neoplasm progression,3,17146473
3,22.1,Pyrexia,1,17146473
4,22.1,Rash,1,17146473
5,22.1,Pruritus,1,17146473
0,22.1,Death,5,17146489
1,22.1,Inappropriate schedule of product administration,6,17146489
0,22.1,Hyperglycaemia,6,17146491
0,22.1,Brain neoplasm,6,17146506
0,22.1,Gastrointestinal ulcer haemorrhage,6,17146581
1,22.1,Rectal haemorrhage,6,17146581
2,22.1,Enzyme induction,6,17146581
3,22.1,International normalised ratio decreased,6,17146581
4,22.1,Haemoglobin decreased,2,17146581
5,22.1,Drug ineffective,6,17146581
6,22.1,Cardioactive drug level decreased,6,17146581
7,22.1,Gastritis erosive,6,17146581
8,22.1,Haematemesis,6,17146581
9,22.1,Venous thrombosis,6,17146581
10,22.1,International normalised ratio abnormal,1,17146581
11,22.1,Gastric ulcer,6,17146581
12,22.1,Drug interaction,6,17146581
13,22.1,Oesophagitis,6,17146581
14,22.1,Drug level decreased,6,17146581
15,22.1,Haemodynamic instability,1,17146581
16,22.1,Gastrointestinal haemorrhage,1,17146581
